Navigation Links
Compounds Identified That Might Treat Nerve Diseases
Date:1/19/2010

Researchers aim to 'chaperone' proteins involved in diseases like Parkinson's

TUESDAY, Jan. 19 (HealthDay News) -- Researchers report that they've developed a new way to find compounds that could become treatments for degenerative nerve disorders such as Alzheimer's, Huntington's and Parkinson's diseases.

The diseases cause proteins in nerve cells known as neurons to "misfold." In the new research, scientists say they've found molecules that play a role in the body's efforts to "chaperone" the molecules that fix the broken proteins.

The scientists studied one of the molecules and used rat neurons to show that it does indeed serve as a protective chaperone. Research in fruit flies showed the same thing.

Researchers say the study could lead to treatments that manipulate the chaperone molecules, leading to repair of the broken proteins.

"We found a creative way to identify new molecules that can activate the body's natural protein-folding machinery," senior author Dennis J. Thiele, professor of pharmacology and cancer biology at Duke University Medical Center in Durham, N.C., said in a news release.

The research appeared in the Jan. 19 online issue of PLoS Biology.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more on Parkinson's disease.



-- Randy Dotinga



SOURCE: Duke University, news release, Jan. 19, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Prenatal exposure to flame-retardant compounds affects neurodevelopment of young children
2. Marijuana Compounds Could Beat Back Brain Cancer
3. Spice Compounds May Stem Tumor Growth
4. Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop and Commercialize Compounds for Obesity
5. Study shows how to boost value of Alzheimers-fighting compounds
6. New class of compounds discovered for potential Alzheimers disease drug
7. Novel light-sensitive compounds show promise for cancer therapy
8. Neuromed Announces that Merck & Co., Inc. Terminates Research Collaboration and License Agreement for Compounds Targeting N-Type Calcium Channels
9. Research Findings on Nine GlaxoSmithKline Cancer Compounds to be Presented at ASCO 2009
10. Newly Identified Compounds May Inhibit Strep Infection
11. PRA SPEAKING EVENT: Phase I Studies with Hepatitis C Compounds in Healthy Volunteers and Patients: Views from Inside
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Dickinson Insurance and ... and financial preparation services, is providing an update on a charitable event that ... City Rescue is a locally recognized nonprofit that provides shelter and care for ...
(Date:10/13/2017)... ... October 13, 2017 , ... While it’s often important ... problem. Fortunately, an inventor from Austin, Texas, has identified a solution. , She developed ... darkness or restricted lighting. As such, it eliminates the need to turn on a ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... the certification process to promote standards of excellence for the field of eating ... for March 22 – 25, 2018 in Orlando, Florida at the Omni Resort ...
(Date:10/13/2017)... Ill. (PRWEB) , ... October ... ... Edwardsville School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer ... healthcare professionals on guideline updates for the primary prevention of cardiovascular diseases ...
(Date:10/13/2017)... Shelton, CT (PRWEB) , ... October 13, 2017 , ... ... and long-term care services, staged a mock evacuation of the facility as part of ... Department, Shelton Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans Bioscience ... the use of wearable and home sensors for real-time ... Early Signal Foundation, a nonprofit organization focused on disruptive ... provide an affordable analytical system to record and integrate ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/18/2017)... , Sept. 18, 2017  PMD Healthcare of ... Pharmacy of Kalamazoo, Mich. , have ... service that expedites and streamlines patient and provider access ... 2.0, and wellness management services.  ... used to measure lung function for a variety of ...
Breaking Medicine Technology: